Complete Filing Data
Dogwood Therapeutics, Inc. reported Stockholders Equity of $74.90 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Dogwood Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$34.3M | -$12.3M | -$5.3M | -$12.2M | -$16.0M | -$10.3M |
| Research And Development Expense | $21.9M | $3.5M | $1.7M | $8.1M | $10.8M | $194.0K |
| Other Nonoperating Income Expense | -$6.1M | -$123.0K | $150.9K | $67.5K | -$319.3K | -$341.0K |
| Operating Income Loss | -$28.0M | -$12.2M | -$5.4M | -$12.3M | -$15.6M | -$10.0M |
| Operating Expenses | $28.0M | $12.2M | $5.4M | $12.3M | $15.6M | $10.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$34.0M | -$12.4M | -$5.3M | -$12.2M | -$16.0M | -$10.3M |
| General And Administrative Expense | $6.1M | $8.7M | $3.7M | $4.2M | $4.8M | $9.8M |
| Interest Income Expense Net | $150.9K | $67.5K | $5.7K | -$384.2K | ||
| Interest Income Expense Nonoperating Net | $96.9K | -$92.2K | $150.9K | |||
| Net Income Loss Available To Common Stockholders Basic | -$35.5M | -$12.9M | -$5.3M | |||
| Comprehensive Income Net Of Tax | -$31.0M | -$16.2M | -$5.3M | |||
| Deferred Income Tax Expense Benefit | $221.1K | -$503.00 | ||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $3.3M | -$3.9M | ||||
| Deferred Income Tax Liabilities Net | $12.1M | $11.3M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$15.7M | -$3.8M | -$10.9M | -$2.3M | -$1.0M | -$1.3M | -$1.2M | -$1.4M | -$1.5M | -$2.6M | -$3.7M | -$4.0M | -$4.1M | -$4.3M | -$3.1M | -$2.7M | -$654.6K | -$466.6K |
| Research And Development Expense | $14.5M | $2.6M | $2.4M | $535.2K | $336.1K | $343.7K | $374.2K | $557.8K | $497.7K | $1.6M | $2.4M | $2.8M | $3.0M | $3.2M | $1.7M | $108.1K | $23.3K | $30.5K |
| Other Nonoperating Income Expense | $63.1K | $115.9K | -$6.3M | $20.5K | $20.0K | $22.8K | $39.2K | $36.3K | $40.4K | $16.6K | $4.8K | $906.00 | $1.5K | $1.5K | $1.4K | -$61.2K | -$116.2K | -$84.0K |
| Operating Income Loss | -$15.8M | -$3.9M | -$4.4M | -$2.3M | -$1.1M | -$1.3M | -$1.3M | -$1.5M | -$1.6M | -$2.6M | -$3.7M | -$4.0M | -$4.1M | -$4.3M | -$3.1M | -$2.7M | -$538.4K | -$382.6K |
| Operating Expenses | $15.8M | $3.9M | $4.4M | $2.3M | $1.1M | $1.3M | $1.3M | $1.5M | $1.6M | $2.6M | $3.7M | $4.0M | $4.1M | $4.3M | $3.1M | $2.7M | $538.4K | $382.6K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$15.7M | -$3.8M | -$10.7M | -$2.3M | -$1.0M | -$1.3M | -$1.2M | -$1.4M | -$1.5M | -$2.6M | -$3.7M | -$4.0M | -$4.1M | -$4.3M | -$3.1M | -$2.7M | -$654.6K | -$466.6K |
| General And Administrative Expense | $1.3M | $1.4M | $2.0M | $1.8M | $733.7K | $970.4K | $900.1K | $919.4K | $1.1M | $969.9K | $1.3M | $1.2M | $1.2M | $1.1M | $1.4M | $2.6M | $515.1K | $352.0K |
| Interest Income Expense Net | $22.8K | $39.2K | $36.3K | $40.4K | $16.6K | $4.8K | $906.00 | $1.5K | $1.5K | $1.4K | -$104.4K | -$116.2K | -$84.0K | |||||
| Interest Income Expense Nonoperating Net | $80.6K | $111.4K | -$147.1K | $20.5K | $20.0K | $22.8K | $39.2K | $36.3K | ||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$15.7M | -$3.8M | -$12.2M | -$2.3M | -$1.0M | -$1.3M | ||||||||||||
| Comprehensive Income Net Of Tax | -$17.1M | -$272.8K | -$10.9M | -$2.3M | -$1.0M | -$1.3M | ||||||||||||
| Deferred Income Tax Expense Benefit | -$1.4K | $149.00 | $190.5K | $0.00 | $0.00 | $0.00 | ||||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$1.4M | $3.5M | $61.2K | |||||||||||||||
| Deferred Income Tax Liabilities Net | $11.9M | $12.1M | $11.5M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $74.9M | -$10.1M | $3.8M | $7.3M | $14.5M | $29.9M | -$5.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.5M | $14.8M | $3.3M | $7.0M | $14.0M | $29.8M | $309.4K |
| Retained Earnings Accumulated Deficit | -$108.1M | -$73.8M | -$61.5M | -$56.2M | -$43.9M | -$28.0M | |
| Prepaid Expense And Other Assets Current | $1.9M | $1.7M | $848.5K | $1.3M | $1.8M | $1.7M | |
| Liabilities Current | $3.1M | $3.2M | $358.5K | $1.0M | $1.3M | $1.5M | |
| Liabilities And Stockholders Equity | $90.2M | $94.3M | $4.2M | $8.4M | $15.8M | $31.5M | |
| Liabilities | $15.3M | $30.0M | $358.5K | $1.0M | $1.3M | $1.5M | |
| Common Stock Value | $3.0K | $133.00 | $77.00 | $1.8K | $833.00 | $830.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$8.3M | $11.7M | -$3.7M | -$7.0M | -$15.8M | $29.5M | |
| Cash And Cash Equivalents At Carrying Value | $6.5M | $14.8M | $3.3M | $7.0M | $14.0M | $29.8M | |
| Assets Current | $8.4M | $16.5M | $4.2M | $8.4M | $15.8M | $31.5M | |
| Assets | $90.2M | $94.3M | $4.2M | $8.4M | $15.8M | $31.5M | |
| Accrued Liabilities Current | $2.2M | $1.9M | $246.6K | $470.1K | $921.8K | $784.1K | |
| Accounts Payable Current | $760.9K | $1.2M | $111.9K | $573.2K | $353.9K | $368.9K | |
| Stockholders Equity Before Treasury Stock | $75.2M | -$9.8M | $4.1M | $7.3M | |||
| Treasury Stock Common Value | $299.1K | $299.1K | $299.1K | ||||
| Treasury Stock Common Shares | 7.7K | 7.7K | 7.7K | ||||
| Treasury Stock Value Acquired Cost Method | $299.1K | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | $74.4M | ||||||
| Property Plant And Equipment Net | $12.8K | $16.8K | |||||
| Operating Lease Right Of Use Asset | $163.1K | $205.8K | |||||
| Operating Lease Liability Noncurrent | $105.8K | $154.9K | |||||
| Operating Lease Liability Current | $56.8K | $49.7K | |||||
| Members Equity | |||||||
| Intangible Assets Net Excluding Goodwill | $69.0M | $65.7M | |||||
| Goodwill | $12.4M | $11.8M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$587.0K | -$3.9M | |||||
| Temporary Equity Accrual Of Paid In Kind Dividends | -$1.3M | -$514.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $7.3M | $6.9M | $7.1M | $949.4K | $3.1M | $2.7M | $4.8M | $4.7M | $6.0M | $9.2M | $7.1M | $10.7M | $18.9M | $22.9M | $27.1M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $10.1M | $13.4M | $17.5M | $2.0M | $3.0M | $2.4M | $4.8M | $4.6M | $5.3M | $9.8M | $7.7M | $11.4M | $19.2M | $21.8M | $24.6M | $499.1K | $1.0M | $1.2M | |
| Retained Earnings Accumulated Deficit | -$104.3M | -$88.6M | -$84.7M | -$66.1M | -$63.8M | -$62.8M | -$60.4M | -$59.1M | -$57.7M | -$54.1M | -$51.6M | -$47.9M | -$39.4M | -$35.3M | -$31.0M | ||||
| Prepaid Expense And Other Assets Current | $1.5M | $1.3M | $1.6M | $243.4K | $615.7K | $845.1K | $462.8K | $622.0K | $1.2M | $1.1M | $1.3M | $1.2M | $920.9K | $1.9M | $3.7M | ||||
| Liabilities Current | $2.6M | $1.9M | $2.6M | $1.3M | $500.1K | $570.1K | $487.1K | $520.0K | $549.3K | $1.6M | $1.9M | $1.9M | $1.2M | $906.3K | $1.2M | ||||
| Liabilities And Stockholders Equity | $92.0M | $96.7M | $97.0M | $2.3M | $3.6M | $3.2M | $5.2M | $5.2M | $6.5M | $10.9M | $9.0M | $12.5M | $20.1M | $23.8M | $28.3M | ||||
| Liabilities | $14.6M | $14.2M | $14.2M | $1.3M | $500.1K | $570.1K | $487.1K | $520.0K | $549.3K | $1.6M | $1.9M | $1.9M | $1.2M | $906.3K | $1.2M | ||||
| Common Stock Value | $229.00 | $191.00 | $191.00 | $111.00 | $2.8K | $1.9K | $1.9K | $1.9K | $1.8K | $1.8K | $833.00 | $833.00 | $833.00 | $833.00 | $833.00 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $2.7M | -$937.4K | -$1.7M | -$2.7M | -$5.2M | $885.1K | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | $10.1M | $13.4M | $17.5M | $2.0M | $3.0M | $2.4M | $4.8M | $4.6M | $5.3M | $9.8M | $7.7M | $11.4M | $19.2M | $21.8M | $24.6M | ||||
| Assets Current | $11.7M | $14.7M | $19.2M | $2.3M | $3.6M | $3.2M | $5.2M | $5.2M | $6.5M | $10.9M | $9.0M | $12.5M | $20.1M | $23.8M | $28.3M | ||||
| Assets | $92.0M | $96.7M | $97.0M | $2.3M | $3.6M | $3.2M | $5.2M | $5.2M | $6.5M | $10.9M | $9.0M | $12.5M | $20.1M | $23.8M | $28.3M | ||||
| Accrued Liabilities Current | $2.0M | $1.3M | $1.4M | $878.9K | $282.3K | $373.3K | $281.8K | $305.7K | $414.2K | $953.7K | $1.2M | $1.5M | $743.3K | $643.7K | $552.6K | ||||
| Accounts Payable Current | $584.6K | $498.1K | $1.2M | $455.0K | $217.8K | $196.8K | $205.4K | $214.3K | $135.1K | $679.4K | $665.5K | $330.7K | $483.5K | $262.6K | $614.7K | ||||
| Stockholders Equity Before Treasury Stock | $7.6M | $7.2M | $7.4M | $1.2M | $3.4M | $3.0M | $5.1M | $5.0M | |||||||||||
| Treasury Stock Common Value | $299.1K | $299.1K | $299.1K | $299.1K | $299.1K | $299.1K | $299.1K | $292.2K | |||||||||||
| Treasury Stock Common Shares | 7.7K | 7.7K | 7.7K | 7.7K | 193.0K | 193.0K | 193.0K | 189.6K | |||||||||||
| Treasury Stock Value Acquired Cost Method | $6.9K | $292.3K | |||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $70.1M | $75.7M | $75.7M | ||||||||||||||||
| Property Plant And Equipment Net | $15.3K | $16.2K | $15.9K | ||||||||||||||||
| Operating Lease Right Of Use Asset | $174.0K | $191.0K | $193.8K | ||||||||||||||||
| Operating Lease Liability Noncurrent | $120.2K | $132.5K | $140.5K | ||||||||||||||||
| Operating Lease Liability Current | $54.6K | $54.5K | $50.7K | ||||||||||||||||
| Members Equity | -$5.2M | -$6.1M | -$5.5M | -$5.0M | |||||||||||||||
| Intangible Assets Net Excluding Goodwill | $67.9M | $69.3M | $65.8M | ||||||||||||||||
| Goodwill | $12.2M | $12.5M | $11.8M | ||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.6M | -$267.3K | -$3.8M | ||||||||||||||||
| Temporary Equity Accrual Of Paid In Kind Dividends | $1.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$15.6M | -$8.8M | -$4.9M | -$11.5M | -$15.7M | -$3.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $208.7K | $498.7K | -$490.3K | -$429.7K | $91.1K | $1.7M |
| Increase Decrease In Accounts Payable | -$532.6K | $219.9K | -$461.3K | $219.3K | $270.0K | $51.6K |
| Share Based Compensation | $355.6K | $476.0K | $620.0K | $582.7K | $322.9K | $7.4M |
| Net Cash Provided By Used In Financing Activities | $7.3M | $16.7M | $1.2M | $4.5M | -$97.6K | $33.4M |
| Increase Decrease In Accrued Liabilities | -$223.5K | -$451.7K | $147.8K | $774.5K | ||
| Increase Decrease In Accrued Salaries | -$378.8K | -$144.3K | ||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $608.3K | -$302.4K | -$223.5K | |||
| Proceeds From Warrant Exercises | $197.6K | $176.3K | ||||
| Proceeds From Issuance Of Common Stock | $1.2M | $5.0M | ||||
| Payments Of Stock Issuance Costs | $53.8K | |||||
| Proceeds From Issuance Initial Public Offering | $4.5M | -$295.2K | $31.3M | |||
| Net Cash Provided By Used In Investing Activities | $3.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$4.7M | -$937.4K | -$1.7M | -$2.7M | -$5.1M | -$277.4K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$71.8K | -$3.4K | -$150.7K | -$570.8K | $2.0M | $6.4K |
| Increase Decrease In Accounts Payable | -$131.5K | $84.8K | -$438.1K | -$23.2K | $530.8K | $73.8K |
| Share Based Compensation | $84.5K | $139.0K | $161.7K | $131.9K | $24.8K | |
| Net Cash Provided By Used In Financing Activities | $7.4M | -$97.6K | $1.2M | |||
| Increase Decrease In Accrued Liabilities | $126.7K | -$55.9K | $624.7K | -$221.4K | $81.8K | |
| Increase Decrease In Accrued Salaries | -$378.8K | $29.2K | ||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$183.4K | $126.7K | ||||
| Proceeds From Warrant Exercises | $197.6K | |||||
| Proceeds From Issuance Of Common Stock | ||||||
| Payments Of Stock Issuance Costs | $295.2K | |||||
| Proceeds From Issuance Initial Public Offering | ||||||
| Net Cash Provided By Used In Investing Activities |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$7.13 | -$12.52 | -$7.05 | -$1.11 | -$1.92 | -$2.10 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M |
| Weighted Average Number Of Shares Outstanding Basic | 5.0M | 1.0M | 751.1K | 11.1M | 8.3M | 4.9M |
| Weighted Average Number Of Diluted Shares Outstanding | 5.0M | 1.0M | 751.1K | 11.1M | 8.3M | 4.9M |
| Preferred Stock Shares Authorized | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | |
| Earnings Per Share Basic | $-7.13 | $-12.52 | $-7.05 | $-1.11 | $-1.92 | $-2.10 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 29.7M | 1.3M | 770.3K | 18.3M | 8.3M | 8.3M |
| Common Stock Shares Issued | 29.8M | 1.3M | 778.0K | 18.3M | 8.3M | 8.3M |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Temporary Equity Shares Outstanding | 0.00 | 2.2K | 0.00 | |||
| Temporary Equity Shares Authorized | 2.1K | 2.3K | 0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | ||||||
| Temporary Equity Shares Issued | 2.1K | 2.2K | 0.00 | |||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$8.20 | -$1.99 | -$8.45 | -$2.05 | -$1.15 | -$1.68 | -$1.62 | -$0.08 | -$0.08 | -$0.28 | -$0.44 | -$0.48 | -$0.49 | -$0.51 | -$0.37 | -$0.56 | -$0.14 | -$0.10 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Authorized | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | |||||
| Weighted Average Number Of Shares Outstanding Basic | 1.9M | 1.9M | 1.4M | 1.1M | 916.0K | 770.3K | 763.8K | 18.4M | 18.3M | 9.2M | 8.3M | 8.3M | 8.3M | 8.3M | 8.3M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 1.9M | 1.9M | 1.4M | 1.1M | 916.0K | 770.3K | 763.8K | 18.4M | 18.3M | 9.2M | 8.3M | 8.3M | 8.3M | 8.3M | 8.3M | |||||
| Preferred Stock Shares Authorized | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | ||||||||
| Earnings Per Share Basic | $-8.20 | $-1.99 | $-8.45 | $-2.05 | $-1.15 | $-1.68 | $-1.62 | $-0.08 | $-0.08 | $-0.28 | $-0.44 | $-0.48 | $-0.49 | $-0.51 | $-0.37 | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Shares Outstanding | 2.3M | 1.9M | 1.9M | 27.8M | 19.3M | 19.3M | 18.3M | 18.3M | 18.3M | 8.3M | 8.3M | 8.3M | 8.3M | 8.3M | ||||||
| Common Stock Shares Issued | 2.3M | 1.9M | 1.9M | 28.0M | 19.5M | 19.5M | 18.8M | 18.3M | 18.3M | 8.3M | 8.3M | 8.3M | 8.3M | 8.3M | ||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Temporary Equity Shares Outstanding | 2.1K | 2.3K | 2.2K | |||||||||||||||||
| Temporary Equity Shares Authorized | 2.1K | 2.3K | 2.2K | 2.2K | ||||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 8.3M | 8.3M | 8.3M | 4.8M | 4.8M | 4.8M | ||||||||||||||
| Temporary Equity Shares Issued | 2.1K | 2.3K | 2.2K | |||||||||||||||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $355.6K | $476.0K | $620.0K | $582.7K | $322.9K | $5.4M |
| Additional Paid In Capital | $183.9M | $67.9M | $65.6M | $63.5M | $58.4M | $57.9M |
| Stock Issued During Period Value Warrants Exercised | $299.1K | $197.6K | $176.3K | |||
| Stock Issued During Period Value New Issues | $1.4M | $4.5M | $31.1M | |||
| Prepaid Expense Noncurrent | $19.0K | $18.1K | ||||
| Foreign Currency Transaction Gain Loss Before Tax | -$27.9K | -$30.8K | ||||
| Stock Issued During Period Shares Warrants Exercised | 25.3K | 961.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $48.3K | $65.0K | $84.5K | $94.3K | $148.9K | $139.0K | $148.3K | $161.7K | $161.7K | $164.3K | $137.0K | $131.9K | $131.9K | $34.2K | $24.8K |
| Additional Paid In Capital | $73.2M | $71.0M | $70.9M | $67.3M | $67.2M | $65.7M | $65.4M | $64.1M | $63.7M | $63.4M | $58.7M | $58.6M | $58.3M | $58.2M | $58.1M |
| Stock Issued During Period Value Warrants Exercised | $6.9K | $292.3K | $197.6K | ||||||||||||
| Stock Issued During Period Value New Issues | $4.3M | $1.4M | $1.2M | $4.5M | |||||||||||
| Prepaid Expense Noncurrent | $18.7K | $19.1K | $18.2K | ||||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | -$17.5K | $4.5K | -$23.3K | ||||||||||||
| Stock Issued During Period Shares Warrants Exercised |
Most recent annual filing with the SEC: March 18, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.